Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Karsten Munk Knudsen
Age : 49
Public asset : 3,468,487 USD
Country of residence : Unknown
Linked companies : Novo Nordisk A/S

Biography of Karsten Munk Knudsen 
Karsten Munk Knudsen is Chief Financial Officer & Executive Vice President of Novo Nordisk A. In the past Mr. Knudsen occupied the position of Principal at A.P. M°ller-MŠrsk A, Head-Finance of NNIT A, VP-Finance & Information Technology at Novo Nordisk, Inc. and Financial Analyst at Nykredit Bank A. He received a graduate degree from the University of Aarhus.


Current positions of Karsten Munk Knudsen 
Karsten Munk Knudsen : Personal Network 
Most Read News 
06/14ELON MUSK : Bitcoin tops $40,000 after Musk says Tesla could use it again
RE
06/07JEFF BEZOS : Amazon's billionaire founder Jeff Bezos to fly to space next month
RE
06/04JACK DORSEY : Square considering making bitcoin hardware wallet -Dorsey
RE
06/01LEON BLACK : Woman's lawsuit accuses Leon Black of defamation, violent behavior
RE
06/02BILL GATES : Bill Gates' next generation nuclear reactor to be built in Wyoming
RE
06/08CHAMATH PALIHAPITIYA : Palihapitiya's $16 million bet on Clover worth $682 million on Reddit rally
RE
06/12JEFF BEZOS : Bid of $28 million wins a rocket trip to space with Bezos
RE
06/04WILLIAM ACKMAN : Ackman reinvents SPAC in Universal Music deal talks
RE
06/11ELON MUSK : 'This car crushes' Musk says, as Tesla launches faster Model S 'Plaid'
RE
06/15JACK MA : Alibaba executive says founder Jack Ma 'lying low' - CNBC
RE
More news


© 2021 People and Ownership :   
Karsten Munk Knudsen : Connections 


Latest news about Karsten Munk Knudsen 
2020NOVO NORDISK A/Sá : tweaks outlook higher after pandemic sales hit
RE
2020NOVO NORDISK A/Sá : tweaks outlook higher after pandemic sales hit
RE
2020NOVO NORDISK A/Sá : tweaks outlook higher after pandemic sales hit
RE
2019Novo Nordisk nudges up 2019 sales outlook as new drugs excel
RE
2018Novo Nordisk A/S Announces Management Changes
CI
More news